1-55056233-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_174936.4(PCSK9):​c.996+44A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.37 ( 16 hom., cov: 0)
Exomes 𝑓: 0.50 ( 880 hom. )
Failed GnomAD Quality Control

Consequence

PCSK9
NM_174936.4 intron

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.84

Publications

0 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.52 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCSK9NM_174936.4 linkc.996+44A>G intron_variant Intron 6 of 11 ENST00000302118.5 NP_777596.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCSK9ENST00000302118.5 linkc.996+44A>G intron_variant Intron 6 of 11 1 NM_174936.4 ENSP00000303208.5

Frequencies

GnomAD3 genomes
AF:
0.371
AC:
910
AN:
2456
Hom.:
15
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.410
Gnomad AMR
AF:
0.240
Gnomad ASJ
AF:
0.0278
Gnomad EAS
AF:
0.500
Gnomad SAS
AF:
0.417
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0556
Gnomad OTH
AF:
0.233
GnomAD2 exomes
AF:
0.0211
AC:
175
AN:
8282
AF XY:
0.0208
show subpopulations
Gnomad AFR exome
AF:
0.0776
Gnomad AMR exome
AF:
0.0147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0500
Gnomad FIN exome
AF:
0.0186
Gnomad NFE exome
AF:
0.0165
Gnomad OTH exome
AF:
0.0357
GnomAD4 exome
AF:
0.496
AC:
21218
AN:
42746
Hom.:
880
Cov.:
0
AF XY:
0.495
AC XY:
9913
AN XY:
20042
show subpopulations
African (AFR)
AF:
0.513
AC:
1110
AN:
2162
American (AMR)
AF:
0.467
AC:
57
AN:
122
Ashkenazi Jewish (ASJ)
AF:
0.248
AC:
141
AN:
568
East Asian (EAS)
AF:
0.507
AC:
214
AN:
422
South Asian (SAS)
AF:
0.547
AC:
1040
AN:
1900
European-Finnish (FIN)
AF:
0.500
AC:
194
AN:
388
Middle Eastern (MID)
AF:
0.500
AC:
61
AN:
122
European-Non Finnish (NFE)
AF:
0.497
AC:
17576
AN:
35346
Other (OTH)
AF:
0.481
AC:
825
AN:
1716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.563
Heterozygous variant carriers
0
857
1715
2572
3430
4287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.371
AC:
912
AN:
2458
Hom.:
16
Cov.:
0
AF XY:
0.376
AC XY:
437
AN XY:
1162
show subpopulations
African (AFR)
AF:
0.411
AC:
849
AN:
2066
American (AMR)
AF:
0.245
AC:
24
AN:
98
Ashkenazi Jewish (ASJ)
AF:
0.0278
AC:
2
AN:
72
East Asian (EAS)
AF:
0.500
AC:
19
AN:
38
South Asian (SAS)
AF:
0.400
AC:
4
AN:
10
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
14
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4
European-Non Finnish (NFE)
AF:
0.0556
AC:
7
AN:
126
Other (OTH)
AF:
0.233
AC:
7
AN:
30
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
38
77
115
154
192
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Uncertain:1
Mar 01, 2016
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.25
DANN
Benign
0.13
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs67578331; hg19: chr1-55521906; API